PROBLEMS EXISTING IN DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) - DISCUSSION

被引：0

作者：

WANG, ZY

CASTAIGNE, S

BERNARD, J

BESSIS, B

CHOMIENNE, C

BEUTLER, E

CRONKITE, EP

DETHE, G

BINET, JL

SACHS, L

BULL, B

DIGHIERO, G

DETHE, H

机构：

[1] HOP ST LOUIS, SERV CLIN MALAD SANG, F-75475 PARIS 10, FRANCE

[2] HOP LA PITIE SALPETRIERE, F-75651 PARIS, FRANCE

[3] HOP ST LOUIS, U93, UNITE RECH IMMUNOGENET TRANSPLANTAT, F-75475 PARIS 10, FRANCE

[4] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA

[5] SCRIPPS CLIN, DIV HEMATOL, LA JOLLA, CA 92037 USA

[6] ASSOCIATED UNIV INC, BROOKHAVEN NATL LAB, DEPT MED, UPTON, NY 11973 USA

[7] BROOKHAVEN NATL LAB, DEPT MED, UPTON, NY 11973 USA

[8] INST PASTEUR, UNITE EPIDEMIOL VIRUS ONCOGENES, F-75724 PARIS 15, FRANCE

[9] INST PASTEUR, UNITE EPIDEMIOL VIRUS ONCOGENES, F-75015 PARIS, FRANCE

[10] WEIZMANN INST SCI, DEPT MOLEC GENET & VIROL, IL-76100 REHOVOT, ISRAEL

[11] LOMA LINDA UNIV HOSP, DEPT PATHOL & LAB MED, LOMA LINDA, CA 92350 USA

来源：

BLOOD CELLS | 1993年 / 19卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：642 / 647

页数：6

共 50 条

[31] Hematological complete remission (HCR) and molecular response induced by liposomal all-trans-retinoic acid (ATRA) in acute promyelocytic leukemia (APL).
Santillana, SS
Faldas, MGL
Williams, AH
Douer, D
Boehm, KA
BLOOD, 2000, 96 (11) : 217B - 217B
[32] All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL)
Orfali, Nina
O'Donovan, Tracey R.
Cahill, Mary R.
Benjamin, Dalyia
Nanus, David M.
McKenna, Sharon L.
Gudas, Lorraine J.
Mongan, Nigel P.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (03) : 236 - 250
[33] EXPRESSION OF EVI1 IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) AND REGULATION OF EVI1 BY ALL-TRANS-RETINOIC ACID (ATRA)
RUSSELL, M
WOODWARD, S
TAETLE, R
BLOOD, 1993, 82 (10) : A250 - A250
[34] Dronabinol induces neutrophilic differentiation comparable to all-trans retinoic acid (ATRA) in native acute promyelocytic leukemia (APL)
Haeusser, L.
Schittenhelm, M.
Vogel, W.
Kanz, L.
Kampa-Schittenhelm, K.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 54 - +
[35] Safety and efficacy of liposomal all-trans-retinoic acid (ATRA) monotherapy in the induction treatment of newly diagnosed acute promyelocytic leukemia (APL).
Douer, D
Faldas, MGL
Williams, AH
Santillana, SS
Pobboravsky, KN
Estey, EH
BLOOD, 2000, 96 (11) : 828A - 828A
[36] STEROID-PROPHYLAXIS FOR THE PULMONARY TOXICITY OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA (APML)
WILEY, JS
FIRKIN, FC
BLOOD, 1993, 82 (10) : A249 - A249
[37] CHANGES IN MICRORHEOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS DURING ALL-TRANS-RETINOIC ACID (ATRA) DIFFERENTIATION THERAPY - A MECHANISM FOR ATRA-INDUCED HYPERLEUKOCYTOSIS
DOMBRET, H
GEIGER, S
DANIEL, MT
GLAISNER, S
MICLEA, JM
CASTAIGNE, S
MERLEBERAL, H
LACOMBE, C
CHOMIENNE, C
DEGOS, L
LEUKEMIA, 1995, 9 (09) : 1473 - 1477
[38] Treatment of adult acute promyelocytic leukemia (APL) with trans-retinoic acid (ATRA).
Perez, S
Lopez-Enriquez, A
Fradera, J
Acaba-Sifontes, L
Castro-Montalvo, J
Hallman-Navarro, D
Martinez-Poventud, G
Pacheco, E
Roman-Diaz, A
Velez-Garcia, E
BLOOD, 2001, 98 (11) : 219B - 219B
[39] ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN
OHNO, R
OHNISHI, K
TAKESHITA, A
TANIMOTO, M
MURAKAMI, H
KANAMARU, A
ASOU, N
KOBAYASHI, T
KURIYAMA, K
OHMOTO, E
SAKAMAKI, H
TSUBAKI, K
HIRAOKA, A
YAMADA, O
OH, H
FURUSAWA, S
MATSUDA, S
NAOE, T
LEUKEMIA, 1994, 8 : S64 - S69
[40] All-trans retinoic acid (ATRA) for acute promyelocytic leukemia (APL) - The Hong Kong scenario.
Chim, CS
Chu, YC
Kwong, YL
Liang, R
Lee, CK
Todd, D
Chan, TK
BLOOD, 1995, 86 (10) : 3000 - 3000

← 1 2 3 4 5 →